Forty patients with alveolar clefts were included in this retrospective study. All patients had a residual edentulous cleft space due to lateral incisive agenesis or avulsion of a microdontic tooth.
The strategy method for the treatment of patient with alveolar cleft involved multi-disciplinary decision in growth stages. The means of reconstruction of the anterior alveolar defect was secondary bone grafting at the age of 8–11 years, while the mixed dentition was present.
Alveolar bone reconstruction was performed with a bone graft, using a gingivoperiosteoplasty technique, during the mixed dentition stage and before permanent canine eruption. Secondary bone grafts were harvested from the anterior iliac crest, using particles of cancellous bone and marrow (24 patients), or from the parietal bone, using bone particles of cortical and cancellous bone (3 patients). Tertiary bone grafting was performed in fully grown patients starting at the age of 17 if needed according to the previous technique.
The restoration of missing teeth in cleft patients with orthodontic gap closure, conventional prosthetics (fixed, removable, or overlay), or dental implants was decided and performed in this stage of fully growth patient.
A single specialized examiner collected all information from patient medical records, pictures, and radiographs. Regardless of the type of rehabilitation, except for one patient who was treated with Disk-implant® (Victory, France) and was excluded, all patients with clefts and dental rehabilitation of the edentulous space treated from 2016 to 2019 were included in this study. Preoperative data were registered for all patients who underwent CLP management. The following scores were used in this study:
-
1.
Alveolar left score (range, 1–14) derived from Molé et Simon’s score [22]
-
2.
Interdental-alveolar bone height score (range, 0–4) determined according to Takahashi et al. [17] and adapted from Abyholm and Bergland [24, 25].
-
3.
Compliance score (range, 0–3).
The ACS (Fig. 1) is a clinical cleft tissue assessment that evaluates seven parameters: the prosthetic space (width), lateral incisor (presence, shape, or anomaly), bordering teeth (with root state), bordering periodontium, epithelial invagination (depth), buccal surface (regularity), and palatal mucosa (inflammation, fistulae). A score of 0 (unfavorable), 1 (possible with local management), or 2 (favorable) is assigned to each parameter.
The IABH score (Fig. 2) was determined in relation to the interdental bone height and assessed on a 4-point scale: 1 (75–100% bone loss), 2 (50–75% bone loss), 3 (25–50% bone loss), and 4 (0–25% bone loss). If the IABH score was estimated to be 3 or 4, cone-beam computer tomography is realized, and the implant could be placed according to the 3D bone volume assessment. If the score was < 2, the patient received a secondary bone graft. The compliance score (range, 0–3) was assigned by two professional examiners, summing dental hygiene (0, good; 1, bad), medical visit observance (0, good; 1, bad), and smoking (0, nonsmoker; 1, smoker). Age and sex were recorded. By adding the ACS, IABH score, and compliance score data, a new combined score named “IABH-ACS-Compliance” (range, 0–21), was suggested to synthesize the oral cleft environment at the time of prosthetic orientation selection.
Subsequently, the edentulous maxillary cleft space was rehabilitated according to a multidisciplinary discussion on mesiodistal space, bone and soft tissue evaluation, occlusion, and patient motivation. The following prosthetic treatments were proposed for the edentulous space: dental implants, fixed prosthodontics, removable dentures, and orthodontic space closure. Patient series was divided in group of patients with dental implant (Group 1) and group of patients with other rehabilitation of the missing tooth space (Group 2) and results of IABH, ACS and compliance were analyzed for each group. After 3-years follow-up, patient satisfaction was assessed in group 1 and group 2, the implant failure and the marginal bone lost (MBL) were assessed in group 1. To proceed with implant surgery, patients underwent cone-beam computed tomography (CBCT) scanning and retro-alveolar radiography examination. A parallel radiography technique was used: the film was placed parallel to the long axis of the neighboring tooth, and the central X-ray beam was directed perpendicular to the long axis of the tooth.
Using the CBCT reconstructed images, we selected implants with the proper diameter and length, considering the available bone (width and length). The interval between implant placement and last grafting (horizontal, vertical, or both) was also recorded. Commercially available pure titanium screw implants with a smooth surface and neck were placed: 15 Zimmer Dental Tapered Screw-Vent® (Zimmer Dental, Carlsbad, USA) and 11 Straumann Bone Level® (Institute Straumann, Waldenburg, Switzerland). The number of implants placed in each patient ranged widely depending on the type of cleft and space between teeth adjacent to the cleft area (including cases of infant premaxillary necrosis). Implant placement was performed in accordance with the recommended submerged surgical protocol. The implant shoulder level was equal to that of the bone crest. Preoperative broad-spectrum antibiotics (amoxicillin 2 g) were administered and continued for one week. All implants were allowed to integrate for four months before implant exposure and subsequent prosthodontic procedures. Soft tissue management around the implants was performed in 24 patients at the second surgery or later. This was done to improve peri-implant conditions. The follow-up period was 36 months after implant surgery or other prosthetic rehabilitations. After three years of follow-up, three data records were complete: implant survival, marginal bone loss (MBL), and patient satisfaction (Fig. 3).
Implant survival was recorded and used to calculate the implant survival rate. Marginal bone loss was evaluated using calibrated CBCT and was defined by the distance, in millimeters, from the implant shoulder to the alveolar crest [26]. The criteria proposed by Albrektsson et al. [27] served as a baseline for evaluating implant success, stipulating that vertical bone loss for osseointegrated implants should be 1.5 mm for the first year, and < 0.2 mm annually thereafter. Consequently, in this study, we considered an MBL of 1.9 mm as the threshold value (1.5 mm for the first year and 0.4 mm for the second and third years).
The patients with implants (group 1) in this study were divided into two groups: “Relative Success” (RS) group (no implants were lost and the MBL was ≤ 1.9 mm after 3 years) and “Relative Failure” (RF) group (one or several implants were lost or the MBL was > 1.9 mm after 3 years).
Final patient satisfaction was measured using the implant crown esthetic index (range, 0–5) [28]. The implant crown esthetic index was well adapted for patients with CLP compared with the pink esthetic score, which was judged too strict for CLP patients. Satisfaction was also evaluated in group 2 (other rehabilitation). The evaluation was performed by the patients themselves and by professional examiners (two maxillofacial surgeons and two dentists).
Ethical approval and consent
All data were retrospectively collected and analyzed from routine cleft procedures. Informed consent for the use of anonymized data from medical records was obtained from the patients participating in the study and their legal representatives. The Institutional Review Board of Head and Neck University Institute (IRB No. 2017–05) approved the study protocol. In addition, our monocentric research on retrospective data meets the requirements of the MR003 (Reference Method 003), number 2202706, of the Commission Nationale de l’Informatique et des Libertés [National Commission for Data Protection].
Statistical analysis
Qualitative data are presented as absolute and relative frequencies and were compared according to the χ2 test or Fisher’s exact test, as necessary. Quantitative data are presented as means and standard deviations, or medians and ranges, and were compared using the Student’s t-test or the Wilcoxon test. The normality of the distribution was tested using the Kolmogorov–Smirnov test. A 3-point difference between mean scores was considered clinically relevant. Considering this hypothesis, the inclusion of 40 patients yielded 90% power for the study. All statistical analyses were two-sided, and a p-value < 0.05 was considered statistically significant. All calculations were performed using R 3.2.2 software.